- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aytu BioScience Inc (AYTU)
Aytu BioScience Inc stock price live, this page displays NASDAQ AYTU stock exchange data. View the AYTU premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Aytu BioScience Inc real time stock price chart below.
What Is the Aytu BioScience Inc Stock Price Today?
The Aytu BioScience Inc stock price today is 2.700.
What Is the Stock Symbol for Aytu BioScience Inc?
The stock symbol for Aytu BioScience Inc is "AYTU."
What Stock Exchange Does Aytu BioScience Inc Trade On?
Aytu BioScience Inc is listed and trades on the NASDAQ stock exchange.
Is Aytu BioScience Inc a Good Stock to Buy?
Determining whether Aytu BioScience Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AYTU quote. (ISIN: US0547548588)
What Is the Aytu BioScience Inc Stock Price Today?
The Aytu BioScience Inc stock price today is 2.700.
What Is the Stock Symbol for Aytu BioScience Inc?
The stock symbol for Aytu BioScience Inc is "AYTU."
What Stock Exchange Does Aytu BioScience Inc Trade On?
Aytu BioScience Inc is listed and trades on the NASDAQ stock exchange.
Is Aytu BioScience Inc a Good Stock to Buy?
Determining whether Aytu BioScience Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AYTU quote. (ISIN: US0547548588)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.660
2.750
52 wk Range
0.950
3.065
AYTU is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.6602.750
52 wk Range
0.9503.065
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AYTU Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
9.333
Upside
+245.68%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales decline in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Aytu BioScience Inc Company Profile
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old; and Metadate CD, a central nervous system stimulant indicated for the treatment of ADHD. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinoxamine (antihistamine) suspension indicated to treat numerous allergic conditions for patients two years and above; and Poly-Vi-Flor and Tri-Vi-Flor complementary prescription fluoride-based multi-vitamin products containing combinations of fluoride and vitamins in liquid and chewable tablet form for infants and children with fluoride deficiency. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu BioPharma, Inc. in March 2021. Aytu BioPharma, Inc. is headquartered in Denver, Colorado.
Aytu BioScience Inc Earnings Call Summary for Q1/2026
- Aytu BioPharma reported Q1 2025 revenue of $13.9 million (down from $16.6 million YoY) with reduced operating expenses of $10.2 million, while maintaining stock stability at $2.06.
- The company holds $32.6 million in cash and equivalents, positioning it for the December 2025 launch of Exxua, a new antidepressant requiring $10 million in launch investment.
- Gross margin declined from 72% to 66% year-over-year, with management projecting a break-even revenue target of $17.3 million per quarter.
- CEO Josh Disbrow described Exxua as a 'game-changing opportunity for major depressive disorder,' indicating a strategic pivot to become 'a strict psychiatry play.'
- Significant revenue impact from Exxua is expected in March and June 2026 quarters, though the company faces challenges from declining revenues and competitive pressures in the antidepressant market.
Last Updated: 2025-11-13, 06:18 p/m
Read Full TranscriptCompare AYTU to Peers and Sector
Metrics to compare | AYTU | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAYTUPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.1x | 15.6x | −0.6x | |
PEG Ratio | 0.11 | −0.62 | 0.00 | |
Price/Book | 1.2x | 1.8x | 2.6x | |
Price / LTM Sales | 0.4x | 3.8x | 3.4x | |
Upside (Analyst Target) | 196.3% | 166.2% | 42.0% | |
Fair Value Upside | Unlock | 7.5% | 5.0% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 9.333
(+245.68% Upside)
Earnings
Latest Release
Nov 13, 2025
EPS / Forecast
-0.08 / --
Revenue / Forecast
13.89M / --
People Also Watch
FAQ
What Is the Aytu BioScience (AYTU) Stock Price Today?
The Aytu BioScience stock price today is 2.700
What Stock Exchange Does Aytu BioScience Trade On?
Aytu BioScience is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Aytu BioScience?
The stock symbol for Aytu BioScience is "AYTU."
What Is the Aytu BioScience Market Cap?
As of today, Aytu BioScience market cap is 27.51M.
What Is Aytu BioScience's Earnings Per Share (TTM)?
The Aytu BioScience EPS (TTM) is -1.95.
From a Technical Analysis Perspective, Is AYTU a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Aytu BioScience Stock Split?
Aytu BioScience has split 6 times.
How Many Employees Does Aytu BioScience Have?
Aytu BioScience has 83 employees.
What is the current trading status of Aytu BioScience (AYTU)?
As of Jan 25, 2026, Aytu BioScience (AYTU) is trading at a price of 2.700, with a previous close of 2.710. The stock has fluctuated within a day range of 2.660 to 2.750, while its 52-week range spans from 0.950 to 3.065.
What Is Aytu BioScience (AYTU) Price Target According to Analysts?
The average 12-month price target for Aytu BioScience is USD9.333, with a high estimate of USD13 and a low estimate of USD7. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +245.68% Upside potential.
What Is the AYTU Premarket Price?
AYTU's last pre-market stock price is 2.630. The pre-market share volume is 930.000, and the stock has decreased by -0.080, or -2.950%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.